Author

W. Nicholson Price

  • Health Care Finance

    HBR/NEJM online forum on health care innovation

    By Nicholson Price For those of you who haven’t seen it yet, there’s a great ongoing online forum over at the joint Harvard Business Review and New England Journal of Medicine Insight Center on Leading…

    HBR/NEJM online forum on health care innovation

    By

    W. Nicholson Price

  • FDA

    Drug manufacturing’s innovation problem

    By Nicholson Price There’s a lot of talk and research about the drug industry, including its levels of innovation, its pricing patterns, transparency of clinical trials, industry changes over time, and how the industry is…

    Drug manufacturing’s innovation problem

    By

    W. Nicholson Price

  • Bioethics

    Experiment vs. innovative treatment in bacterial transplants

    By Nicholson Price There’s a fascinating and tragic story coming to its conclusion at UC Davis, which points at the fine line between clinical innovation and experimental treatment.  Two neurosurgeons just resigned, following the resignation…

    Experiment vs. innovative treatment in bacterial transplants

    By

    W. Nicholson Price

  • Bioethics

    Henrietta Lacks and the HeLa genome

    By Nicholson Price A few days ago, NIH announced an agreement with the family of Henrietta Lacks.  When she was being treated for an aggressive tumor, cells were taken without her consent or knowledge and used…

    Henrietta Lacks and the HeLa genome

    By

    W. Nicholson Price

  • Criminal Law

    Importing unapproved drugs: lethal injections and shortages

    By Nicholson Price In a unanimous opinion (pdf) in Cook v. FDA, the DC Circuit just held that FDA must prohibit the importation of misbranded or unapproved new drugs, including those made by unapproved manufacturers…

    Importing unapproved drugs: lethal injections and shortages

    By

    W. Nicholson Price

  • Health Care Reform

    Employer mandate delayed for a year.

    By Nicholson Price The employer mandate has been delayed for a year, until 2015.  Under this provision of the Affordable Care Act, all employers with more than 50 employees are obliged to provide health insurance…

    Employer mandate delayed for a year.

    By

    W. Nicholson Price

  • Biotechnology

    Reactions to Myriad, two weeks later

    By Nicholson Price Two weeks after the Supreme Court held isolated naturally occurring DNA unpatentable in Association for Molecular Pathology v. Myriad Genetics, Inc., there’s been quite a lot of commentary about the case’s implications…

    Reactions to Myriad, two weeks later

    By

    W. Nicholson Price

  • Antitrust

    Supreme Court deals a major blow to reverse-payment settlements.

    By Nicholson Price The Supreme Court keeps coming out with major opinions in the biotech/pharma area, with today seeing a major blow to reverse-payment settlements wherein brand-name pharma companies pay generic companies to delay their…

    Supreme Court deals a major blow to reverse-payment settlements.

    By

    W. Nicholson Price

  • Food

    Unapproved GMO wheat found in Oregon; Japan cancels US wheat imports.

    By Nicholson Price One fear about GMOs is that they will escape whatever controls are placed them and end up in the wild.  A version of that story appears to have come true in the…

    Unapproved GMO wheat found in Oregon; Japan cancels US wheat imports.

    By

    W. Nicholson Price

  • Biotechnology

    Monsanto v. Bowman: Patents on GMO Seeds

    By Nicholson Price Monsanto has been receiving quite a bit of press recently.  Marchers in over 400 cities protested the company and the GMOs it makes took place a few days ago, arguing that foods…

    Monsanto v. Bowman: Patents on GMO Seeds

    By

    W. Nicholson Price